Heparin and low molecular weight heparin decrease nitric oxide production by human polymorphonuclear cells

Beltran, AE; Concepcion, F; Manzanares, D; Garrido, G; Glaria, LA; Rojas, A

Abstract

Background Heparin and heparin derivatives with low anticoagulant activity exhibit a wide spectrum of biological functions affecting adhesion, activation and trafficking of leukocytes. Methods. We investigated the in vitro effect of heparin and a low molecular weight heparin derivative (LMWH) on nitric oxide (NO) production by human polymorphonuclear leukocytes (PMN). Results. N-formyl-methionyl-leucyl-phenylalanine (fMLP)-stimulated NO production was significantly decreased by heparin at doses of 0.5 and 5 mu g/mL, while LMWH was only effective at doses of 50 and 200 mu g/mL by means of a mechanism not related to NO synthase (NOS) activity. Conclusions. These results support the hypothesis that heparin and LMWH derivatives may offer therapeutic benefit for inflammatory diseases where NO plays a protagonic role. (C) 1999 IMSS. Published by Elsevier Science Inc.

Más información

Título según WOS: ID WOS:000080522900008 Not found in local WOS DB
Título de la Revista: ARCHIVES OF MEDICAL RESEARCH
Volumen: 30
Número: 2
Editorial: Elsevier Science Inc.
Fecha de publicación: 1999
Página de inicio: 116
Página final: 119
DOI:

10.1016/S0188-0128(99)00004-4

Notas: ISI